Associate Pooja Nair was quoted in a Reuters story, “GSK-Linked Investigators Stand Trial in China in Closely Watched Case,” on August 8, 2014. The article analyzed a case involving a British investigator, Peter Humphrey, and his American wife who were arrested following their work for the pharmaceutical company GlaxoSmithKline. Nair was quoted saying, “In the past, people were almost encouraged to turn a blind eye to where the due diligence companies or investigators were getting their information…(This case) makes it clear that in order to get information you’re taking a huge risk in China.”
Related News
June 26, 2025
In the News
Alejandro Gomez-Strozzi on Mexico-US Auto Parts Trade – 'Going forward, there is nothing but integration'
Foley & Lardner lLP partner Alejandro Gómez-Strozzi shared insights on foreign direct investment around Mexico's automotive parts sector in the El Economista article, "Efecto Trump pega más a IED en autopartes que en autos y camiones."
June 25, 2025
In the News
Jocelyn Lavallo Explores Nuclear's Emerging Role in Project Finance
Foley & Lardner LLP partner Jocelyn Lavallo examined the increasing relevance of advanced nuclear technologies in the evolving clean energy landscape in her Environment+Energy Leader article, "Nuclear’s Emerging Role in Project Finance: A Cross-Technology Perspective."
June 25, 2025
In the News
Kyle Faget Comments on AI, User Fees Ahead of MDUFA Negotiations
Foley & Lardner LLP partner Kyle Faget weighed in on the role of user fees and artificial intelligence as stakeholders prepare for the next Medical Device User Fee Amendments (MDUFA) reauthorization in the Medtech Insight article, "Will Kennedy And Makary Come To Terms On User Fees During Next Round Of MDUFA Negotiations?"